Related Experiment Video

Updated: Jul 6, 2026

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
09:46

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Published on: September 14, 2009

Progression of nonculprit plaque stenosis following successful percutaneous intervention

T Jared Bunch1, Charanjit S Rihal, Richard J Gumina

  • 1Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. bunch.thomas18@mayo.edu

Angiology
|April 5, 2008
PubMed

Insights

Patients treated for acute coronary syndrome remain at high risk for recurrent events. This case highlights that coronary artery disease is systemic, with new blockages developing even after successful intervention.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Atherosclerosis Research

Background:

  • Patients with acute coronary syndrome (ACS) face a significant risk of recurrent cardiovascular events within the first year post-intervention.
  • Atherosclerotic plaque rupture can affect multiple coronary sites, not just the primary culprit lesion, in various ischemic heart disease presentations.
  • Percutaneous coronary intervention (PCI) aims to restore blood flow but does not eliminate the risk of disease progression elsewhere.

Observation:

  • A 71-year-old male presented with exertional angina and underwent successful PCI for a right coronary artery lesion.
  • Four weeks later, the patient experienced accelerated angina, indicating a worsening condition.
  • A previously identified lesion in the obtuse marginal artery had progressed from 30% to 90% stenosis.

Findings:

  • The case illustrates that acute coronary syndromes have a systemic component, affecting the entire coronary vasculature.
  • Coronary artery disease (CAD) exhibits inherent instability, with rapid progression of non-culprit lesions possible.
  • The development of a new severe stenosis in a remote artery underscores the multifocal nature of atherosclerosis.

Implications:

  • Aggressive secondary prevention strategies are crucial for patients with ACS and established CAD.
  • Continuous monitoring and risk factor management are essential due to the dynamic nature of atherosclerotic disease.
  • This case supports the need for comprehensive treatment approaches that address the systemic aspects of CAD beyond the index lesion.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...